Live · 17 Sep 2026 SPX 7,551.81 -0.45% NDX 28,945.06 +0.02% VIX 15.47 -12.65% GOLD 4,409.90 +0.51% CL 99.64 -2.72% BTC 76,719.83 +0.75%
NAS100 28,945 +0.02% S&P 7,552 −0.45% GOLD $4,410 +0.51% BTC $76,720 +0.75% VIX 15.47 −12.65% live tape · as of 15:00 UTC
The Screen · Healthcare · Health Information Services

OneMedNet Corp

ONMD · NASDAQ · USD · Market cap $39M · 22 employees

OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.

FAIL · Does not pass the screen
0.68 USD

At the last full screen
2025-12-31

Screened 2025-12-31 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

OneMedNet Corp holds its Markdown at $0.68. The statistical read favours the sellers, held for 47 days.

As held on the ledger · 2025-12-31
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 47 days
Price at the screen$0.68
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 70.0
Beta1.14
The Workings

Five Screens, Shown in Full

Does not pass. Accounts receivable

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 26.50% Below 33% Interest-bearing debt is just 26.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 23.52% Below 33% Cash held in interest-bearing accounts and securities is 23.5% of assets, under the one-third limit. Pass
Receivables 50.21% Below 49% Money owed to the company is 50.2% of assets, above the 49% limit. Fail
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Business, in Plain Words
The fundamentals · plain-English read
EPS, trailing-0.04
Revenue growth-29.9%revenue is shrinking
Profit margin-254.3%currently unprofitable
FCF yield-24.92%
Current ratio0.27below 1: short-term bills exceed liquid assets
Beta1.14moves a little more than the market
Short interest, float0.01%
52-week range0.44 - 4.22
MoatNONE
Market cap$39M
Employees22

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ONMD trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-08 Markdown $0.68 +0.0% Entry 5

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. Insiders have been net buyers over the past quarter.

2026-08-07 Markdown $0.68 +25.1% Entry 4

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 25.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%.

2026-07-18 Markdown $0.54 +0.0% Entry 3

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%.

2026-07-03 Markdown $0.54 +0.0% Entry 2

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Markdown $0.54 Entry 1

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in ONMD's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · ONMD
DateInsiderTitleTypeSharesValue
2026-09-10 Yu Jeffrey Chief Medical Officer, 10% P - Purchase 142,857 $90,000
2026-07-30 Kosasa Thomas Dir, 10% P - Purchase 1,449,275 $1,000,000

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.98 -39.2% · $608 -39.2%
2 months $0.83 -28.3% · $717 -28.3%
3 months $0.78 -24.0% · $760 -24.0%
6 months $1.59 -62.5% · $375 -62.5%
1 year $0.44 +37.0% · $1,370 +37.0%
2 years $1.41 -57.7% · $423 -57.7%
3 years $10.90 -94.5% · $55 -94.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ONMD does next, these words stay.

OneMedNet Corp · ONMD · Markdown · $0.68
Recorded 2025-12-31 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.